InvestorsHub Logo
Followers 23
Posts 3078
Boards Moderated 0
Alias Born 07/15/2016

Re: Alan Brochstein post# 35950

Wednesday, 08/30/2017 10:58:23 AM

Wednesday, August 30, 2017 10:58:23 AM

Post# of 65781
75% and 15 day low is much better than 55% and 30 day low. but assuming they covert next year in JUL/AUG the full $1M in notes will cost 133M shares today or ~10% equity and 1.3M later on (assuming 100/1 r/s)

$500K of the first round of notes already went to the MA lab acquisition.

I'm not sure what this round of funding was for either closing out the MA contract or it's going to fund South CA lab.

I'm not sure if this will convert or be paid off. Either way there will be dilution. IMHO 10% equity to get CA off the ground right now is worth it. At this stage in the game it's the only financing option available and even going forward I suspect SGBY will need to lean on some kind of equity based financing going forward. I would like to see them get away from the convertible notes and maybe file an S1 so we attract a long term investor over a 'cash out' convertible note 'bank'. We'll see what happens after the r/s as the share structure stands today an S1 would never fly.